Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
congress
3
×
detroit blog main
detroit top stories
life sciences
national
3
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
ceo
drug prices
indiana blog main
indiana top stories
pbms
pharmacy benefit managers
pricing
sanofi
senate
2019
abbvie
activism
acute hepatic porphyria
What
bio
drug
roundup
advanced
alnylam’s
approval
away
bff
big
bosley's
bosley’s
bridge
bringing
bucks
cas
ceo
ceos
conference
crime
crispr
dc
deals
departure
devoted
disease
easl
editas
executives
exit
form
gathered
gene
groups
guiding
hearing
held
katrine
kicked
liver
lower
Language
Current search:
congress
×
biotech
×
national
×
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More